In a significant development in a major consumer product safety case, Brazilian cleaning products manufacturer Ypê has filed a formal appeal with the National Health Surveillance Agency (Anvisa). The move comes in direct response to a recent resolution that mandated the immediate suspension of manufacturing, commercialization, and a nationwide recall for several of its detergent, liquid soap, and disinfectant lines.
The company's appeal specifically targets the resolution concerning products with lot numbers ending in the digit 1. According to Ypê, the filing of this legal recourse automatically suspends the effects of the original prohibition until Anvisa issues a new pronouncement on the matter. The company bases this interpretation on Article 17 of Anvisa's own RDC 266/2019 regulation.
In an official statement, Ypê emphasized that the appeal was submitted to reinforce the commitments outlined in its Action and Compliance Plan. Furthermore, the company stated it used the appeal to provide additional technical clarifications and subsidies related to the agency's decision, aiming to present a more complete picture of its corrective measures.
The categories of products affected by the now-suspended order include dishwashing liquids, concentrated dish soaps, liquid laundry detergents, and disinfectants. The recall and production halt had initially sent shockwaves through the market and raised concerns among consumers about the safety of products already in their homes.
Despite the legal maneuver resulting in a temporary pause of the enforcement, Ypê was quick to reaffirm its core message. "Even though the filing of the appeal has resulted in the suspension of the effects of the previous measure, Ypê reinforces that the safety of its consumers is—and always will be—its greatest priority," the company's statement read.
The manufacturer, which highlights its 75-year history in the market, also reiterated its long-standing commitment to quality, safety, and transparency. It expressed its intention to maintain constant and permanent dialogue with Anvisa and other relevant authorities, always guided by scientific criteria and technical evidence.
The ultimate goal, according to Ypê, is to find a definitive solution to the current situation in the shortest time possible. The company's proactive stance aims to reassure both regulators and the public of its dedication to resolving the issue conclusively.
As of the latest reports, Anvisa has not yet publicly confirmed whether it accepts the company's legal interpretation that the appeal automatically suspends the original resolution. The agency's official position on this procedural point is still awaited, leaving the final status of the products in a state of legal and regulatory limbo. Based on reporting from g1.